Vanguard Group’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$823K Sell
1,853,891
-284,858
-13% -$126K ﹤0.01% 3792
2025
Q1
$1.21M Sell
2,138,749
-19,106
-0.9% -$10.8K ﹤0.01% 3656
2024
Q4
$4.55M Buy
2,157,855
+3,803
+0.2% +$8.02K ﹤0.01% 3311
2024
Q3
$5.79M Buy
2,154,052
+36,136
+2% +$97.2K ﹤0.01% 3215
2024
Q2
$6.04M Sell
2,117,916
-34,231
-2% -$97.6K ﹤0.01% 3174
2024
Q1
$9.13M Buy
2,152,147
+49,576
+2% +$210K ﹤0.01% 3012
2023
Q4
$11.2M Buy
2,102,571
+38,169
+2% +$204K ﹤0.01% 2878
2023
Q3
$8.88M Buy
2,064,402
+102,385
+5% +$440K ﹤0.01% 2945
2023
Q2
$10.8M Buy
1,962,017
+218,021
+13% +$1.2M ﹤0.01% 2903
2023
Q1
$7.32M Buy
1,743,996
+486,198
+39% +$2.04M ﹤0.01% 3112
2022
Q4
$3.48M Sell
1,257,798
-280,485
-18% -$777K ﹤0.01% 3460
2022
Q3
$3.94M Hold
1,538,283
﹤0.01% 3442
2022
Q2
$5.54M Sell
1,538,283
-386,234
-20% -$1.39M ﹤0.01% 3330
2022
Q1
$12M Buy
1,924,517
+218,832
+13% +$1.36M ﹤0.01% 3054
2021
Q4
$12M Sell
1,705,685
-96,020
-5% -$677K ﹤0.01% 3119
2021
Q3
$12.6M Sell
1,801,705
-124,163
-6% -$867K ﹤0.01% 3117
2021
Q2
$16M Buy
1,925,868
+402,541
+26% +$3.35M ﹤0.01% 2945
2021
Q1
$8.32M Sell
1,523,327
-310,389
-17% -$1.69M ﹤0.01% 3250
2020
Q4
$7.87M Sell
1,833,716
-192,381
-9% -$825K ﹤0.01% 3122
2020
Q3
$6.1M Sell
2,026,097
-121,172
-6% -$365K ﹤0.01% 3045
2020
Q2
$6.66M Buy
2,147,269
+144,370
+7% +$448K ﹤0.01% 2960
2020
Q1
$4.43M Buy
2,002,899
+541,700
+37% +$1.2M ﹤0.01% 3019
2019
Q4
$4.46M Buy
1,461,199
+144,600
+11% +$441K ﹤0.01% 3207
2019
Q3
$4.05M Sell
1,316,599
-475,243
-27% -$1.46M ﹤0.01% 3214
2019
Q2
$3.58M Sell
1,791,842
-44,806
-2% -$89.6K ﹤0.01% 3281
2019
Q1
$7.92M Sell
1,836,648
-5,152
-0.3% -$22.2K ﹤0.01% 2948
2018
Q4
$5.86M Buy
1,841,800
+29,399
+2% +$93.5K ﹤0.01% 3017
2018
Q3
$9.52M Buy
1,812,401
+254,493
+16% +$1.34M ﹤0.01% 2942
2018
Q2
$8.33M Buy
1,557,908
+194,502
+14% +$1.04M ﹤0.01% 2995
2018
Q1
$6.82M Sell
1,363,406
-179,128
-12% -$896K ﹤0.01% 3013
2017
Q4
$5.09M Sell
1,542,534
-30,535
-2% -$101K ﹤0.01% 3131
2017
Q3
$5.9M Buy
1,573,069
+33,048
+2% +$124K ﹤0.01% 3054
2017
Q2
$3.93M Buy
1,540,021
+25,582
+2% +$65.2K ﹤0.01% 3177
2017
Q1
$3.94M Buy
1,514,439
+22,440
+2% +$58.3K ﹤0.01% 3154
2016
Q4
$4.55M Buy
1,491,999
+3,876
+0.3% +$11.8K ﹤0.01% 3096
2016
Q3
$4.05M Buy
1,488,123
+59,213
+4% +$161K ﹤0.01% 3109
2016
Q2
$4.09M Sell
1,428,910
-56,543
-4% -$162K ﹤0.01% 3078
2016
Q1
$4.49M Buy
1,485,453
+51,649
+4% +$156K ﹤0.01% 3017
2015
Q4
$4.98M Buy
1,433,804
+306,016
+27% +$1.06M ﹤0.01% 2985
2015
Q3
$4.26M Buy
1,127,788
+18,747
+2% +$70.9K ﹤0.01% 3042
2015
Q2
$6.32M Buy
1,109,041
+55,111
+5% +$314K ﹤0.01% 2894
2015
Q1
$6.13M Buy
1,053,930
+31,980
+3% +$186K ﹤0.01% 2894
2014
Q4
$5.8M Buy
1,021,950
+24,525
+2% +$139K ﹤0.01% 2816
2014
Q3
$4.08M Buy
997,425
+86,341
+9% +$353K ﹤0.01% 2938
2014
Q2
$4.15M Sell
911,084
-18,739
-2% -$85.3K ﹤0.01% 2936
2014
Q1
$4.41M Buy
929,823
+38,971
+4% +$185K ﹤0.01% 2891
2013
Q4
$4.19M Sell
890,852
-239,813
-21% -$1.13M ﹤0.01% 2884
2013
Q3
$4.51M Buy
1,130,665
+19,783
+2% +$78.9K ﹤0.01% 2798
2013
Q2
$3.98M Buy
+1,110,882
New +$3.98M ﹤0.01% 2784